Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Epidemiology. 2023 Oct 11;35(1):84–93. doi: 10.1097/EDE.0000000000001682

Table 1.

Sociodemographic characteristics of the mother-child pairs and distributions of six phthalate metabolites during pregnancy in the analytic sample of HOME and EARLI (N = 437).

HOME (N=271) EARLI (N=166) Pooled (N=437)
MATERNAL CHARACTERISTICS
Maternal age at delivery (years) 29.0 (19.0, 45.0) 34.0 (22.0, 44.0) 32.0 (19.0, 45.0)
Maternal race/ethnicity, n(%)
  Hispanic or Latino 7 (3%) 33 (20%) 40 (9%)
  Non-Hispanic black 84 (31%) 15 (9%) 99 (23%)
  Non-Hispanic white 168 (62%) 92 (55%) 260 (59%)
  Other/multiple races 12 (4%) 26 (16%) 38 (9%)
Parity a
  0–2 251 (93%) 136 (82%) 387 (89%)
  >2 20 (7%) 30 (18%) 50 (11%)
Pre-pregnancy BMI (kg/m2) 24.7 (15.8, 51.3) 26.6 (17.8, 58.4) 25.5 (15.8, 58.4)
Household annual income, $; n(%)
  0–10,000 46 (17%) 6 (4%) 52 (12%)
  10,001–20,000 19 (7%) 4 (2%) 23 (5%)
  20,001–30,000 20 (7%) 7 (4%) 27 (6%)
  30,001–50,000 42 (16%) 24 (14%) 66 (15%)
  50,001–75,000 42 (16%) 29 (18%) 71 (16%)
  75,001–100,000 58 (21%) 31 (19%) 89 (20%)
  100,001–200,000 44 (16%) 53 (32%) 97 (22%)
  >200,000 0 (0%) 12 (7%) 12 (3%)
MBP (ug/g creatinine), median (min, max) 26.3 (4.5, 557.0) 14.5 (2.2, 217.6) 21.6 (2.2, 557.0)
MBzP (ug/g creatinine), median (min, max) 11.1 (0.6, 185.1) 6.7 (0.3, 238.6) 9.2 (0.3, 238.6)
MCPP (ug/g creatinine), median (min, max) 2.4 (0.6, 55.2) 2.4 (0.4, 2811.1) 2.4 (0.4, 2811.1)
DEHP (ug/g creatinine), median (min, max) b 88.0 (16.3, 3809.8) 41.3 (7.4, 1135.7) 63.6 (7.4, 3809.8)
MEP (ug/g creatinine), median (min, max) 152.3 (11.1, 9158.9) 34.5 (2.5, 2279.4) 94.0 (2.5, 9158.9)
MiBP (ug/g creatinine), median (min, max) 5.3 (0.8, 48.3) 10.3 (1.8, 317.7) 6.9 (0.8, 317.7)
CHILD CHARACTERISTICS
Child sex at birth, n(%)
  Female 149 (55%) 76 (46%) 225 (52%)
  Male 122 (45%) 90 (54%) 212 (48%)
Age at SRS administration (months), median (min, max) 50.1 (45.2, 125.2) 36.3 (35.0, 50.2) 48.6 (35.0, 125.2)
SRS total raw scores (points), median (min, max) c 30.0 (1.0, 126.0) 29.0 (6.0, 174.0) 30.0 (1.0, 174.0)
SRS total T-scores (unitless), median (min, max) 50.0 (35.0, 90.0) 45.0 (36.0, 101.0) 48.0 (35.0, 101.0)
STUDY SITE, n(%)
  HOME 271 (100%) 0 (0%) 271 (62%)
  Drexel 0 (0%) 41 (25%) 41 (9%)
  Johns Hopkins University 0 (0%) 39 (23%) 39 (9%)
  Kaiser Permanente 0 (0%) 58 (35%) 58 (13%)
  UC Davis 0 (0%) 28 (17%) 28 (6%)
a

All the pregnant women in EARLI had prior pregnancies by study design.

b

DEHP (ug/g creatinine) was calculated as ΣDEHP (ug/g creatinine) = [MEHP (ug/g creatinine)/278 (g/mol) + MEOHP (ug/g creatinine)/292 (g/mol) + MEHHP (ug/g creatinine)/294 (g/mol) + MECPP (ug/g creatinine)/308 (g/mol)] × 308 g/mol where 278, 292, 294, and 308 are the molecular weights of mono-2-ethylhexyl phthalate (MEHP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-carboxypentyl phthalate (MECPP), respectively.

c

SRS had 65 items, each of which was scored as 0 (“not true”), 1 (“sometimes true”), 2 (“often true”), or 3 (“almost always true”). The total raw score was a sum of all these 65 items.

All values are sample sizes (column percentages) for categorial variables and medians (minimums, maximums) for continuous variables unless otherwise specified. Maternal urinary phthalates concentrations were imputed with the lower limit of detection (LLOD) divided by square root of two if lower than the LLOD and corrected for urinary dilution using creatinine.

BMI, body mass index; DEHP, di(2-ethylhexyl) phthalate; EARLI, the Early Autism Risk Longitudinal Investigation Study; HOME, the Health Outcomes and Measures of the Environment Study; MBP, mono-n-butyl phthalate; MBzP, monobenzyl phthalate; MCPP, mono-3-carboxypropyl phthalate; MEP, monoethyl phthalate; MiBP, mono-isobutyl phthalate; SRS, Social Responsiveness Scale.